MedTrace Logo

Spirulina Platensis for PPI Withdrawal

NCT04988347 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-08-03

No results posted yet for this study

Summary

Background: Rebound acid hypersecretion after proton pump inhibitors (PPIs) discontinuation may be accompanied by dyspepsia.

Aim: To assess whether Spirulina platensis, by its anti-inflammatory properties, could minimize rebound symptoms after PPIs withdrawal.

Conditions

  • Gastro Esophageal Reflux Disease
  • Dyspepsia
  • Rebound Acid Hypersecretion

Interventions

COMBINATION_PRODUCT

Spirulina platensis

Active treatment with Spirulina platensis in capsules containing 530 mg, 1 capsule orally each 8 hours, for 60 days

OTHER

Placebo comparator

Placebo in capsules, 1 capsule orally each 8 hours, for 60 days

Sponsors & Collaborators

  • Universidade de Passo Fundo

    lead OTHER

Principal Investigators

  • Fernando Fornari, Professor · University of Passo Fundo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-02-29
Completion
2012-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04988347 on ClinicalTrials.gov